Jared L. Crandon

2.6k total citations
63 papers, 2.1k citations indexed

About

Jared L. Crandon is a scholar working on Pharmacology, Molecular Medicine and Epidemiology. According to data from OpenAlex, Jared L. Crandon has authored 63 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Pharmacology, 43 papers in Molecular Medicine and 24 papers in Epidemiology. Recurrent topics in Jared L. Crandon's work include Antibiotics Pharmacokinetics and Efficacy (47 papers), Antibiotic Resistance in Bacteria (43 papers) and Pneumonia and Respiratory Infections (19 papers). Jared L. Crandon is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (47 papers), Antibiotic Resistance in Bacteria (43 papers) and Pneumonia and Respiratory Infections (19 papers). Jared L. Crandon collaborates with scholars based in United States, France and Japan. Jared L. Crandon's co-authors include David P. Nicolau, Joseph L. Kuti, Abrar K. Thabit, Mary Anné Banevicius, Dora E. Wiskirchen, Wright W. Nichols, Anthony M. Nicasio, Rebecca A. Keel, Catharine C. Bulik and Sheryl Zelenitsky and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, The Journal of Urology and Intensive Care Medicine.

In The Last Decade

Jared L. Crandon

62 papers receiving 2.0k citations

Peers

Jared L. Crandon

PHARM

EPIDE

AMB

Elizabeth B. Hirsch United States

Michael D. Huband United States

Angela Raffaella Losito Italy

Evelyn J. Ellis‐Grosse United States

Francesco Cristini Italy

Andrew Denisuik Canada

Karen E. Bowker United Kingdom

Alfred S. Gin Canada

Cecília G Carvalhaes United States

Simona Barnini Italy

Elizabeth B. Hirsch United States

Jared L. Crandon

658 ×0.5

PHARM

1.2k ×0.9

578 ×0.8

EPIDE

380 ×0.9

AMB

238 ×0.6

Citations per year, relative to Jared L. Crandon Jared L. Crandon (= 1×) peers Elizabeth B. Hirsch

Countries citing papers authored by Jared L. Crandon

Since Specialization

Citations

This map shows the geographic impact of Jared L. Crandon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jared L. Crandon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jared L. Crandon more than expected).

Fields of papers citing papers by Jared L. Crandon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jared L. Crandon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jared L. Crandon. The network helps show where Jared L. Crandon may publish in the future.

Co-authorship network of co-authors of Jared L. Crandon

This figure shows the co-authorship network connecting the top 25 collaborators of Jared L. Crandon. A scholar is included among the top collaborators of Jared L. Crandon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jared L. Crandon. Jared L. Crandon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Reidenberg, Bruce E., Stephen G. Jenkins, Jared L. Crandon, et al.. (2024). In vitro activity of taurolidine against clinical Candida auris isolates: relevance to catheter-related bloodstream infections. Antimicrobial Agents and Chemotherapy. 68(7). e0038124–e0038124. 1 indexed citations

Crandon, Jared L., et al.. (2016). Evaluation of a disease state management guideline for urinary tract infection. International Journal of Antimicrobial Agents. 47(6). 451–456. 3 indexed citations

Ghazi, Islam M., Jared L. Crandon, Emil Lesho, Patrick McGann, & David P. Nicolau. (2016). In vivo efficacy of humanized high dose meropenem and comparators against Pseudomonas aeruginosa isolates producing verona integron-encoded metallo-β-lactamase (VIM). Heliyon. 2(6). e00121–e00121. 2 indexed citations

Crandon, Jared L., Charles‐Édouard Luyt, Alexandra Aubry, Jean Chastre, & David P. Nicolau. (2016). Pharmacodynamics of carbapenems for the treatment ofPseudomonas aeruginosaventilator-associated pneumonia: associations with clinical outcome and recurrence. Journal of Antimicrobial Chemotherapy. 71(9). 2534–2537. 28 indexed citations

Thabit, Abrar K., Jared L. Crandon, & David P. Nicolau. (2016). Pharmacodynamic and pharmacokinetic profiling of delafloxacin in a murine lung model against community-acquired respiratory tract pathogens. International Journal of Antimicrobial Agents. 48(5). 535–541. 47 indexed citations

So, Wonhee, Jared L. Crandon, & David P. Nicolau. (2015). Poor outcomes of empiric ceftriaxone ± azithromycin for community-acquired pneumonia caused by methicillin-susceptible Staphylococcus aureus. Internal and Emergency Medicine. 11(4). 545–551. 6 indexed citations

Sutherland, Christina, Jared L. Crandon, & David P. Nicolau. (2015). Defining Extended Spectrum β-Lactamases: Implications of Minimum Inhibitory Concentration-Based Screening Versus Clavulanate Confirmation Testing. Infectious Diseases and Therapy. 4(4). 513–518. 2 indexed citations

So, Wonhee, Jared L. Crandon, Yukihiro Hamada, & David P. Nicolau. (2015). Antibacterial activity of achievable epithelial lining fluid exposures of Amikacin Inhale with or without meropenem. Journal of Antimicrobial Chemotherapy. 71(2). 428–437. 12 indexed citations

Bhalodi, Amira A., Jared L. Crandon, G. Williams, & David P. Nicolau. (2014). Supporting the ceftaroline fosamil/avibactam Enterobacteriaceae breakpoint determination using humanised in vivo exposures in a thigh model. International Journal of Antimicrobial Agents. 44(6). 508–513. 1 indexed citations

10.

Hagihara, Mao, Jared L. Crandon, Carl Urban, & David P. Nicolau. (2013). Efficacy of doripenem and ertapenem against KPC-2-producing and non-KPC-producing Klebsiella pneumoniae with similar MICs. Journal of Antimicrobial Chemotherapy. 68(7). 1616–1618. 16 indexed citations

11.

Wiskirchen, Dora E., Jared L. Crandon, & David P. Nicolau. (2013). Impact of various conditions on the efficacy of dual carbapenem therapy against KPC-producing Klebsiella pneumoniae. International Journal of Antimicrobial Agents. 41(6). 582–585. 37 indexed citations

12.

Wiskirchen, Dora E., Patrice Nordmann, Jared L. Crandon, & David P. Nicolau. (2013). Efficacy of Humanized Carbapenem and Ceftazidime Regimens against Enterobacteriaceae Producing OXA-48 Carbapenemase in a Murine Infection Model. Antimicrobial Agents and Chemotherapy. 58(3). 1678–1683. 41 indexed citations

13.

Hagihara, Mao, Jared L. Crandon, Carl Urban, & David P. Nicolau. (2012). KPC Presence in Pseudomonas aeruginosa Has Minimal Impact on the In Vivo Efficacy of Carbapenem Therapy. Antimicrobial Agents and Chemotherapy. 57(2). 1086–1088. 9 indexed citations

14.

Crandon, Jared L., Robert E. Ariano, Sheryl Zelenitsky, et al.. (2010). Optimization of meropenem dosage in the critically ill population based on renal function. Intensive Care Medicine. 37(4). 632–638. 83 indexed citations

15.

Crandon, Jared L. & David P. Nicolau. (2010). Pharmacodynamic Approaches to Optimizing Beta-Lactam Therapy. Critical Care Clinics. 27(1). 77–93. 17 indexed citations

16.

Koomanachai, Pornpan, Jared L. Crandon, & David P. Nicolau. (2009). Newer developments in the treatment of Gram-positive infections. Expert Opinion on Pharmacotherapy. 10(17). 2829–2843. 13 indexed citations

17.

Crandon, Jared L., et al.. (2009). Comparison of tigecycline penetration into the epithelial lining fluid of infected and uninfected murine lungs. Journal of Antimicrobial Chemotherapy. 64(4). 837–839. 38 indexed citations

18.

Crandon, Jared L., Catharine C. Bulik, & David P. Nicolau. (2009). In Vivo Efficacy of 1- and 2-Gram Human Simulated Prolonged Infusions of Doripenem against Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy. 53(10). 4352–4356. 29 indexed citations

19.

Crandon, Jared L.. (2008). Pharmacodynamics of Tigecycline Against Phenotypically Diverse Staphylococcus aureus. 46th Annual Meeting. 2 indexed citations

20.

Koomanachai, Pornpan, Jared L. Crandon, Joseph L. Kuti, & David P. Nicolau. (2008). Comparative pharmacodynamics for intravenous antibiotics against Gram-negative bacteria in Europe between 2002 and 2006: a report from the OPTAMA program. International Journal of Antimicrobial Agents. 33(4). 348–353. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact